NCT06184464View on ClinicalTrials.gov

Prostatic Size Reduction Following of Leuprorelin Acetate

RecruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

February 2, 2024

Primary Completion Date

December 15, 2024

Study Completion Date

December 15, 2024

Conditions
Prostate Cancer AdenocarcinomaProstate Adenocarcinoma
Interventions
OTHER

ACETATE LEUPRELINE

USE ACETATE LEUPRELINE BEFORE AND AFTER PROSTATE DELIMITATION

Trial Locations (1)

08225

RECRUITING

Hospital de Terrassa, Terrassa

All Listed Sponsors
lead

Consorci Sanitari de Terrassa

OTHER